Metropolitan Life Insurance Company (MetLife)’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,670
| Closed | -$181K | – | 1872 |
|
2024
Q1 | $181K | Sell |
3,670
-206
| -5% | -$10.1K | 0.01% | 758 |
|
2023
Q4 | $141K | Buy |
3,876
+512
| +15% | +$18.7K | 0.01% | 908 |
|
2023
Q3 | $77.8K | Buy |
3,364
+179
| +6% | +$4.14K | ﹤0.01% | 1159 |
|
2023
Q2 | $83.5K | Buy |
+3,185
| New | +$83.5K | ﹤0.01% | 1117 |
|
2023
Q1 | – | Sell |
-2,154
| Closed | -$56K | – | 2457 |
|
2022
Q4 | $56K | Buy |
2,154
+248
| +13% | +$6.45K | ﹤0.01% | 1403 |
|
2022
Q3 | $54.4K | Hold |
1,906
| – | – | ﹤0.01% | 1412 |
|
2022
Q2 | $46.9K | Hold |
1,906
| – | – | ﹤0.01% | 1548 |
|
2022
Q1 | $108K | Sell |
1,906
-5,529
| -74% | -$312K | ﹤0.01% | 1151 |
|
2021
Q4 | $461K | Sell |
7,435
-644
| -8% | -$39.9K | 0.01% | 1492 |
|
2021
Q3 | $513K | Buy |
+8,079
| New | +$513K | 0.01% | 1448 |
|
2021
Q2 | – | Sell |
-6,439
| Closed | -$474K | – | 2870 |
|
2021
Q1 | $474K | Sell |
6,439
-217
| -3% | -$16K | 0.01% | 1455 |
|
2020
Q4 | $483K | Hold |
6,656
| – | – | 0.01% | 1373 |
|
2020
Q3 | $317K | Hold |
6,656
| – | – | 0.01% | 1508 |
|
2020
Q2 | $280K | Buy |
6,656
+3,132
| +89% | +$132K | 0.01% | 1593 |
|
2020
Q1 | $95.1K | Sell |
3,524
-2,336
| -40% | -$63.1K | ﹤0.01% | 2054 |
|
2019
Q4 | $226K | Buy |
+5,860
| New | +$226K | ﹤0.01% | 1831 |
|